Articles for the ‘General’ Category

Forthcoming changes to the public health insurance system in the Czech Republic: what you need to know

Published 03 May 2024 by Kateřina Slavíková HAVEL & PARTNERS | Czech Republic, Czech Republic

As with many healthcare systems worldwide, the Czech Republic faces challenges regarding sustainable funding and escalating healthcare costs, particularly concerning chronic and rare diseases.

Aiming to address emerging needs in public healthcare, on 12 April 2024, the Ministry of Health of the Czech Republic introduced a draft amendment to the Act on Public Health Insurance and other related laws, which is proposed to take effect on 1 January 2026. In this article, we provide an overview of the key areas affected by the legislative proposal, namely (i) price and reimbursement regulation of medicinal products and medical devices, (ii) preventive care support, (iii) reimbursement of cross-border healthcare services, and (iv) dental care reimbursement.

... Read more

Changes in the law on marketing of veterinary medicines: what you need to know

Published 06 February 2024 by Christophe Ronse ALTIUS Lawyers, Belgium

Belgium is welcoming a significant development in the field of veterinary medicine law. The Act of 11 July 2023 containing various provisions on health, which entered into force on 8 September 2023, introduces changes across a wide spectrum of healthcare domains, which are encompassed in approximately 20 chapters. In this blog post, we provide an overview of the key changes related to the marketing of veterinary medicines set out in Chapters 4 and 14 of the new Law.

... Read more

The advertising of medical devices in Austria

Published 05 February 2024 by Francine Brogyányi DORDA Rechtsanwälte GmbH, Austria

In every jurisdiction the advertising of medical devices comes with certain national peculiarities. The following article explains in more detail what needs to be considered if you intend to market medical devices to the Austrian market

... Read more

The Court of Justice’s New Ruling – Finnish Strict Liability Regime regarding Unfounded Preliminary Injunctions Compatible with the EU Enforcement Directive

Published 01 February 2024 by Ben Rapinoja Borenius Attorneys Ltd, Finland

The Court of Justice of the European Union (the “Court of Justice”) handed down its judgment in case C‑473/22 (Mylan v. Gilead and Others) at the beginning of January 2024. The case concerned the Finnish compensation regime that can be invoked when a preliminary injunction is found to have been unfounded. This compensation regime is based on the concept of strict liability.

Although the judgment primarily concerns compensation claims subject to the Finnish law, the judgment has implications in all EU jurisdictions where a similar strict liability regime exists. The Court of Justice’s judgment provides clarity for cases where an intellectual property right is first used to justify a preliminary injunction and then subsequently found invalid.

... Read more

The UK Life Sciences Sector in Election Year

Published 30 January 2024 by Ralph CoxRalph Cox Clyde & Co. LLP, United Kingdom

Clyde & Co – UK Life Sciences Sector in Election Year (Jan 2024; rev Feb 24) The next UK general election has to take place before 28 January 2025, current indications are that it could take place in October or November 2024. After 13 years in power, opinion polls suggest that Mr Sunak’s Conservative Party will lose power and be replaced by Sir Keir Starmer KC’s Labour as the governing party.

In this article, Ralph Cox and Nii-Lante Bannerman of Clyde & Co LLP, consider the Conservative Government’s approach to the UK’s life sciences sector over recent years and how that might change under Labour.

... Read more